NCT02728219

Comparison of Treatment of Recurrent HCC With Repeat Hepatectomy,and TACE With AFP Conversion

A Prospective Randomized Trial Comparing Treatment of Recurrent HCC With Repeat Hepatectomy,and Transcatheter Arterial Chemoembolization (TACE) With AFP Conversion

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 150 (actual)
• Sponsor: Eastern Hepatobiliary Surgery Hospital · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to compare the treatment of recurrent hepatocellular carcinoma with repeat hepatectomy,and transcatheter arterial chemoembolization (TACE) with AFP conversion.

Detailed description

Though many HCC patients have been benefited from hepatectomy treatment, still the high recurrence rate after the hepatectomy led to limited effectiveness. This is the first study in same case system on comparison of effectiveness among repeat hepatectomy, and TACE with AFP conversion.

Conditions

• Recurrent Hepatocellular Carcinoma

Interventions

Type	Name	Description
PROCEDURE	TACE	In this study we prospectively select some early diagnosed recurrent HCC patients after radical resection with AFP conversion, then they will be treated with transcatheter arterial chemoembolization (TACE)
PROCEDURE	Hepatectomy	Repeat Hepatectomy after postoperation recurrence

Timeline

• Start date: 2012-05-01
• Primary completion: 2014-11-01
• Completion: 2015-05-01
• First posted: 2016-04-05
• Last updated: 2016-04-05

Locations

1 site across 1 country: China